Concepedia

Author

Ignacio Aldana

Universidad de Navarra

Also Known As

I Aldana, I Ortiz Aldana, I Ortíz Aldana, I. ALDANA, I. Aldana, I. Ortiz Aldana, Ignacio Aldana, Ignacio Ortiz Aldana

138

Publications

3.2K

Citations

37

H-Index

54

Concepts

All Affiliations

Universidad de NavarraUniversité Toulouse III - Paul SabatierUniversidad de AntioquiaInstitut de Recherche pour le DéveloppementPharmacochimie et Pharmacologie pour le Développement
IA

About

Ignacio Aldana is an author at Universidad de Navarra specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

32

1.6K

2

Natural Sciences

19

27

1.3K

3

Engineering

6

6

352

4

Health Sciences

1

1

32

5

Allergy

1

1

16

Ignacio Aldana

×

60

Publications

2.9K

Citations

35

H-Index

YearCitations

Synthesis of New Quinoxaline-2-carboxylate 1,4-Dioxide Derivatives as Anti-<i>Mycobacterium </i><i>t</i><i>uberculosis</i> Agents

Andrés Jaso, Belén Zarranz, Ignacio Aldana,

Journal of Medicinal Chemistry

2004

219

Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues

Asunción Burguete, Eleni Pontiki, Dimitra Hadjipavlou‐Litina,

Bioorganic & Medicinal Chemistry Letters

2007

146

Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-Oxide derivatives

Belén Zarranz, Andrés Jaso, Ignacio Aldana,

Bioorganic & Medicinal Chemistry

2003

128

Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents

Andrés Jaso, Belén Zarranz, Ignacio Aldana,

European Journal of Medicinal Chemistry

2003

115

Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides

Esther Vicente, Silvia Pérez‐Silanes, Saioa Ancizu,

Bioorganic & Medicinal Chemistry

2008

108

Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates

Nelilma Correia Romeiro, Gabriela Aguirre, Paola Hernández,

Bioorganic & Medicinal Chemistry

2008

105

Novel Benzo[<i>b</i>]thiophene Derivatives as New Potential Antidepressants with Rapid Onset of Action

Luis Berrade, Bárbara Aisa, Silvia Galiano,

Journal of Medicinal Chemistry

2011

105

Synthesis and Biological Evaluation of New Quinoxaline Derivatives as Antioxidant and Anti‐Inflammatory Agents

Asunción Burguete, Eleni Pontiki, Dimitra Hadjipavlou‐Litina,

Chemical Biology & Drug Design

2011

104

Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives

Belén Zarranz, Andrés Jaso, Ignacio Aldana,

Bioorganic & Medicinal Chemistry

2004

102

Quinoxaline N,N′-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure–activity relationships

Gabriela Aguirre, Hugo Cerecetto, Rossanna Di Maio,

Bioorganic & Medicinal Chemistry Letters

2004

81

Page 1